About Sekwon Jang, MD
Dr. Sekwon Jang is a specialty care physician board certified in internal medicine, hematology, and medical oncology. He has a special interest in management of melanoma and other skin cancers including cutaneous lymphoma.
Dr. Jang serves as Director of Melanoma and Cutaneous Oncology Therapeutics and Research and Director of Quality at Inova Comprehensive Cancer and Research Institute. Before joining Inova, Dr. Jang served as Assistant Professor of Medicine at Georgetown University School of Medicine and Co-Chair of melanoma research group at MedStar Georgetown Cancer Network.
Dr. Jang believes in a covenant relationship with his patients, and his goal is to provide the best quality patient-centered care in the setting of multidisciplinary collaboration.
- Associate Professor, Department of Medicine, Virginia Commonwealth University
- Honor Award, Korean Academy of Medical Science
- Merit Award, American Society of Clinical Oncology
- Travel Award, American Society of Hematology
- Member, Quality of Care Committee, American Society of Clinical Oncology
Inova Melanoma Symposium Offers Resources and Hope. June 4, 2018
Education and Inspiration at Inova's First Melanoma Patient Symposium. June 3, 2016
New Findings in Cancer Immunotherapy: Inova Experts Weigh In. March 29, 2016
Experts from Inova Schar Cancer Institute's Melanoma and Skin Cancer Center Speak at Largest Annual Meeting of Dermatologists. March 16, 2016
Yervoy®: A New Option for Patients with Stage III Melanoma after Surgery. November 10, 2015
Cold Sore Virus as Melanoma Treatment. November 3, 2015
Immunotherapies Offer New Hope for Melanoma Patients. October 9, 2015